Stock listing

TLX1N Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: TLX1N · BIVA · MXN · MX

The TLX1N:BIVA listing represents Telix Pharmaceuticals Limited, a company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer. Recently, Telix has been active in advancing its pipeline and engaging with regulatory bodies to support its product offerings. The company regularly updates its investors through filings and announcements, reflecting its commitment to transparency and growth in the biopharmaceutical sector. As the market evolves, Telix continues to position itself as a key player in the oncology space.

TLX1N:BIVAMXNMXUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
TLX1/N:BIVA
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
BIVA
Currency
MXN

Telix Pharmaceuticals Limited TLX1N:BIVA stock context

The TLX1N:BIVA listing represents Telix Pharmaceuticals Limited, a company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer. Recently, Telix has been active in advancing its pipeline and engaging with regulatory bodies to support its product offerings. The company regularly updates its investors through filings and announcements, reflecting its commitment to transparency and growth in the biopharmaceutical sector. As the market evolves, Telix continues to position itself as a key player in the oncology space.

Research Telix Pharmaceuticals Limited

Alternate listings